The healthcare community is awaiting critical updates from the Drug Enforcement Administration (DEA) on the future of telehealth prescribing for controlled substances, particularly as pandemic-era flexibilities expire at the end of 2024. These DEA telehealth regulations will directly affect how medical professionals can prescribe treatments using telehealth systems for conditions like opioid use disorder (OUD), […]
Menu
